Company / SG&A per Share
Corbus Pharmaceuticals Holdings, Inc. SG&A per Share History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$4.90
FY2022
5-year range
$0.16 / $4.90
FY2018-FY2022
Trend
+1600.3%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share changed +1600% YoY in FY2022, a notable deviation from the 7-year average annual change of +261%.
Based on SEC 10-K filings.
4.90 in FY2022 with a 5-year CAGR of +119.5%.
Increased from $0.37 to $4.90 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +178.7%
- 5-Year CAGR
- +119.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, sg&a per share increased 1600.3% year-over-year.
- Lowest sg&a per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -12.48 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $4.90 | +1600.3% |
| FY2021 | $0.29 | -21.2% |
| FY2020 | $0.37 | +61.5% |
| FY2019 | $0.23 | +40.4% |
| FY2018 | $0.16 | +67.8% |
| FY2017 | $0.10 | +0.0% |
| FY2016 | $0.10 | +79.1% |
| FY2015 | $0.05 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026